Pharmaceutical
| Tue 20 Jan 2026
Alexandria, Jan. 20 -- Merck Sharp & Dohme has obtained a patent for 2-oxo-oxazolidine-5-carboxamides as nav1.8 inhibitors. This invention was developed by Arasappan Ashok, Bell Ian M, Bungard Christopher James, Burgey Christopher S, Cox Jason Michael, Guiadeen Deodial Guy, Kelly Iii Michael J, Layton Mark E, Liu Hong, Liu Jian,..